| CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis. | |
| | |
MedLine Citation:
|
PMID: 22546857 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
PAX5, a B cell-specific transcription factor, is overexpressed through chromosomal translocations in a subset of B cell lymphomas. Previously, we had shown that activation of immunoreceptor tyrosine-based activation motif (ITAM) proteins and B cell receptor (BCR) signaling by PAX5 contributes to B-lymphomagenesis. However, the effect of PAX5 on other oncogenic transcription factor-controlled pathways is unknown. Using a MYC-induced murine lymphoma model as well as MYC-transformed human B cell lines, we found that PAX5 controls c-MYC protein stability and steady-state levels. This promoter-independent, posttranslational mechanism of c-MYC regulation was independent of ITAM/BCR activity. Instead it was controlled by another PAX5 target, CD19, through the PI3K-AKT-GSK3β axis. Consequently, MYC levels in B cells from CD19-deficient mice were sharply reduced. Conversely, reexpression of CD19 in murine lymphomas with spontaneous silencing of PAX5 boosted MYC levels, expression of its key target genes, cell proliferation in vitro, and overall tumor growth in vivo. In human B-lymphomas, CD19 mRNA levels were found to correlate with those of MYC-activated genes. They also negatively correlated with the overall survival of patients with lymphoma in the same way that MYC levels do. Thus, CD19 is a major BCR-independent regulator of MYC-driven neoplastic growth in B cell neoplasms. |
| | |
Authors:
|
Elaine Y Chung; James N Psathas; Duonan Yu; Yimei Li; Mitchell J Weiss; Andrei Thomas-Tikhonenko |
Related Documents
:
|
22447927 - Sequence variation in promoter of ica1 gene, which encodes protein implicated in type 1... 22333587 - Akt and pax3-fkhr cooperation enforces myogenic differentiation blockade in alveolar rh... 19567707 - The maize transcription factor knotted1 directly regulates the gibberellin catabolism g... 22378757 - Neurog3 is a critical downstream effector for stat3-regulated differentiation of mammal... 21454057 - Expression of c-kit, p-erk and cyclin d1 in malignant melanoma: an immunohistochemical ... 12798287 - Cell proliferation is necessary for the determination of male fate in the gonad. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-5-1 |
Journal Detail:
|
Title: The Journal of clinical investigation Volume: - ISSN: 1558-8238 ISO Abbreviation: - Publication Date: 2012 May |
Date Detail:
|
Created Date: 2012-5-1 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7802877 Medline TA: J Clin Invest Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intr...
Next Document: SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice.